´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ ISAAR 2024 & Annual Conference of the KSAT(1ÀÏÂ÷) : 2024-04-08
±³À°ÀÏÀÚ : 2024-04-08
±³À°Àå¼Ò : ±×·£µå ÀÎÅÍÄÁƼ³ÙÅ» ¼¿ï Æĸ£³ª½º
±³À°ÁÖÁ¦ : ISAAR 2024 & Annual Conference of the KSAT(1ÀÏÂ÷)
ÁÖÃÖ±â°ü : ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ(18.7 ¸íĪº¯°æ ´ëÇÑÈÇпä¹ýÇÐȸ)
´ã´çÀÚ : ¹Ú½ÂÀ±
¿¬¶ôó : 02-557-1755
À̸ÞÀÏ : ksc@ksac.or.kr
±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀÎ : 700¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ¼¿ïƯº°½Ã
±³À°½Ã°£ : 9 ½Ã°£ 50ºÐ
¼¼ºÎ¼ö°·á : 665,600¿ø
ºñ°í <pre-registration> *°øÅë : Accompanying USD100 (1) Delegate USD 500 (2) Fellow µî USD250 (3) student free <regular> (1) Delegate USD 600 (2) Fellow µî USD350 (3) student free
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 08:40~09:05 Epidemiology and Prevalence of CRE/CPE Hyukmin Lee(Severance Hospital Yonsei University College of Medicine)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 09:05~09:30 Survey on the Current State of CRE Antibiotic Treatment and Guidelines for Antibiotic Use in CRE Infections in Korea Se Yoon Park(Hanyang University Hospital)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 09:30~09:55 The reality of treatment for CRE/CPE infection in clinical setting in Korea Young Kyung Yoon(Korea University College of Medicine)
Åä·Ð 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 09:55~10:00 Q&A ( )
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 10:00~10:25 Establishment of education system for experts training in antimicrobial stewardship program Ki Tae Kwon(Kyungpook National University School of Medicine)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 10:25~10:50 Quantitative evaluation of antimicrobial use and feedback to individual hospitals: suggestion for the use of KONAS result Bongyoung Kim(Hanyang University College of Medicine)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 10:50~11:15 Evaluating Antimicrobial Utilization in Korean Long-Term Care Hospitals: A Call to Action for Antimicrobial Stewardship Yong Chan Kim(Yonsei University College of Medicine)
Åä·Ð 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 11:15~11:20 Q&A ( )
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 13:00~13:30 SYM1: Mechanisms and Epidemiology of Multiresistant Non-Fermenters David Livermore(University of East Anglia)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 13:30~14:00 SYM1: Clinical Implications and Treatment of Serious Infections due to Carbapenem Resistant Pseudomonas Aeruginosa David Paterson(National University of Singapore)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 1 14:00~14:30 SYM1: Epidemiology and Treatment of Serious Infections Due to Carbapenem Resistant Acinetobacter baumannii. Anucha Apisarnthanarak(Thammasat University Hospital)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 2 13:00~13:30 SYM2 : Inborn errors of cytosolic RNA sensors and severe COVID-19 Helen Su(National Institute of Allergy and Infectious Diseases National Institutes of Health)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 2 13:30~14:00 SYM2 : Vaccination in post-pandemic era and impact on long COVID David Lye(National Centre for Infectious Diseases Singapore)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 2 14:00~14:30 SYM2 : Viral shedding kinetics in patients with SARS-CoV-2 infection Sung-Han Kim(Asan Medical Center)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 3 13:00~13:30 SYM3 : The current situation of antimicrobial stewardship programs and health policy in Japan Masayuki Maeda(Showa University School of Pharmacy)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 3 13:30~14:00 SYM3 : Cutting-Edge Antimicrobial Stewardship: Strategies for Optimizing Therapy and Curbing Resistance in the Modern Era Sara Cosgrove(Johns Hopkins University School of Medicine)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë 3 14:00~14:30 SYM3 : Integrating Emerging Technologies: Pioneering the Next Frontier in Antimicrobial Stewardship Se Yoon Park(Hanyang University Seoul Hospital)
ÈÞ½Ä 04¿ù 08ÀÏ 14:30~15:00 Coffee Break ( )
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë1,2,3, 15:00~15:40 Is antibiotic resistance stoppable? David Livermore(University of East Anglia)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë1,2,3, 15:40~16:20 The Modern World of Infectious Diseases: A Growing Challenge (Video) Michael T. Osterholm(University of Minnesota)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë1,2,3, 16:20~17:00 Vaccines for AMR: an Overview Jerome H. Kim(International Vaccine Institute)
±³À°½Ã°£ 04¿ù 08ÀÏ ±×·£µåº¼·ë1,2,3, 17:00~17:40 Update on Actions and Opportunities on Antimicrobial Resistance at NIH/NIAID Dennis M. Dixon(National Institute of Allergy and Infectious Diseases)